PDCD1 and neoplasm: Type II endometrial cancer and poorly differentiated histological features are generally associated with worse prognosis and, in addition, PD-1 axis expression suggests that it may cause immunosuppression to favor tumor growth, thus negatively affecting patients' survival (5).